Twice-a-Year Injection Gives Women Full Protection Against HIV, Trial Finds
MONDAY, June 24, 2024 (HealthDay News) — Just two injections a year of a new HIV drug protected young women in Africa from infection with the sexually transmitted disease, new trial results show. In announcing the findings, Gilead Sciences Inc. said its HIV medication lenacapavir demonstrated 100% efficacy as aContinue Reading